Study directory

Depression studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
6115studies shown
Showing 4,717-4,728 of 6,115
Drug study icon
CompletedNCT02670538

Efficacy of a Fixed-dose Regimen of Cariprazine Compared to Placebo for depression

This study is completed in the United States, in Bulgaria, in Croatia, .... It is testing Efficacy of a Fixed-dose Regimen of Cariprazine Compared to Placebo for depression.

Multiple locations, including Birmingham
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States, Bulgaria, Croatia, ...
Sponsor
Forest Laboratories
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT01305408

Armodafinil Treatment (150 mg/Day) for depression

This study is completed in the United States, in Argentina, in Brazil, .... It is testing Armodafinil Treatment (150 mg/Day) for depression.

Multiple locations, including Birmingham
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 65 Years
Countries
United States, Argentina, Brazil, ...
Sponsor
Cephalon
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT01072630

Armodafinil Treatment for depression

This study is completed in the United States, in Australia, in France, .... It is testing armodafinil Treatment for depression.

Multiple locations, including Birmingham
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 65 Years
Countries
United States, Australia, France, ...
Sponsor
Cephalon
Condition
Bipolarity, Depression
Device study icon
CompletedNCT01644747

tDCS as an add-on Treatment for Resistant Major Depression in Uni- or Bipolar Patients

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Besançon
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 65 Years
Countries
France
Sponsor
Centre Hospitalier Universitaire de Besancon
Condition
Bipolarity, Depression
Drug study icon
TerminatedNCT00005015

Treatment of Depression in Youth With Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrugFrom 8 Years to 18 Years
Countries
Sponsor
National Institute of Mental Health (NIMH)
Condition
Bipolarity, Depression
Biological study icon
Not recruitingEUCTR 2013-001955-11

A pilot study to treat emotional disorders in Primary Care with evidence-based psychological techniques: A randomized controlled trial

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Spain
Why is this study shown?

This study includes Depression among several conditions.

Anxiety, DepressionBiological
Countries
Spain
Sponsor
Psicofundación. Fundación Española para Promoción, Desarrollo Científico y Profesional de la Psicología
Condition
Anxiety, Depression
Behavioral study icon
SuspendedISRCTN33129243

Cognitive behavioural therapy to reduce anxiety and depression in atrial fibrillation

This public ISRCTN record appears to relate to anxiety. HopeStage keeps this listing available so people can review the official source, understand the basic study status, and decide what questions to ask before contacting the research team.

In United Kingdom
Why is this study shown?

This study includes Depression among several conditions.

Anxiety, DepressionOtherOver 18 Years
Countries
United Kingdom
Sponsor
University of Birmingham
Condition
Anxiety, Depression
Device study icon
Active Not RecruitingNCT07057024

Contribution of Virtual Reality Eye Tracking in the Identification of Schizophrenia, Bipolar and Depression

This observational study is following people with mental health conditions to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

In Étampes
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, Depression, ...OtherFrom 18 Years to 60 Years
Countries
France
Sponsor
Etablissement Public de Santé Barthélemy Durand
Condition
Bipolarity, Depression, ...
Behavioral study icon
Active Not RecruitingNCT03484494

Low Field Magnetic Stimulation: Imaging Biomarkers in Geriatric Depression in bipolarity

This observational study is following people with bipolarity, Depression in bipolarity, Bipolarity I, or Bipolarity II to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

In Belmont
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionBehavioralOver 50 Years
Countries
United States
Sponsor
Mclean Hospital
Condition
Bipolarity, Depression
Biological study icon
Active Not RecruitingNCT03349528

Probiotics to Prevent Relapse After Hospitalization for Depression in bipolarity

This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand whether this type of care can better prevent setbacks and support longer-term stability.

In Towson
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionBiologicalFrom 18 Years to 65 Years
Countries
United States
Sponsor
Sheppard Pratt Health System
Condition
Bipolarity, Depression
Drug study icon
Active Not RecruitingNCT05065294

Psilocybin Therapy for Depression in Bipolarity type II

This study is looking at determine the safety, tolerability, and feasibility of psilocybin therapy in people with Bipolarity II. Participants receive a study treatment and complete follow-up visits and assessments.

In San Francisco
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 70 Years
Countries
United States
Sponsor
University of California, San Francisco
Condition
Bipolarity, Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.